Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Overview01:19

Modified-Release Drug Delivery Systems: Overview

Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Method of Early RRMS Diagnosis Using OCT-Assessed Structural Retinal Data and Explainable Artificial Intelligence.

Translational vision science & technology·2025
Same author

Neuritogenesis and protective effects activated by Angiotensin 1-7 in astrocytes-neuron interaction.

Neuropeptides·2024
Same author

Mechanomyography-Based Metric Scale for Spasticity: A Pilot Descriptive Observational Study.

Sensors (Basel, Switzerland)·2024
Same author

Differential Study of Retinal Thicknesses in the Eyes of Alzheimer's Patients, Multiple Sclerosis Patients and Healthy Subjects.

Biomedicines·2023
Same author

Diagnosis of multiple sclerosis using optical coherence tomography supported by artificial intelligence.

Multiple sclerosis and related disorders·2023
Same author

Objective Diagnosis of Fibromyalgia Using Neuroretinal Evaluation and Artificial Intelligence.

International journal of clinical and health psychology : IJCHP·2022
Same journal

Starmate: A Lightweight AI Assistant for Autism Caregivers Developed and Evaluated Through a User-Centered Mixed-Methods Framework.

Journal of medical systems·2026
Same journal

Predicting the Predictor: Unresolved Validity Threats in LLM-Based ASA Classification.

Journal of medical systems·2026
Same journal

Development and Internal Validation of a Vectorcardiography-Augmented Model for 12-Month Major Adverse Cardiovascular Events in Chronic Heart Failure.

Journal of medical systems·2026
Same journal

Development and Validation of an Automated Acute Kidney Injury E-Alert System Integrated with Clinical Decision Support for Hospitalized Patients.

Journal of medical systems·2026
Same journal

Calibration of Self-Reported Confidence and Accuracy of Large Language Models in Medical Question Answering.

Journal of medical systems·2026
Same journal

Throughput Benchmarking and Throughput Variance Analysis to Evaluate the Efficiency of an Outpatient Endoscopy Unit.

Journal of medical systems·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2026

Disposable Dosators Intended for Dry Powder Delivery to Mice
04:59

Disposable Dosators Intended for Dry Powder Delivery to Mice

Published on: August 18, 2023

Dynamically programmable electronic pill dispenser system.

Luciano Boquete1, Jose Manuel Rodriguez-Ascariz, Irene Artacho

  • 1Electronics Department, Alcala University, Alcalá de Henares, Spain. luciano@depeca.uah.es

Journal of Medical Systems
|May 28, 2010
PubMed
Summary
This summary is machine-generated.

This study introduces a novel dynamically programmable e-pill dispensing system for improved medication compliance. The system offers remote programming and reconfiguration, enhancing dosage control and treatment efficacy.

More Related Videos

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

Generation of Dynamical Environmental Conditions using a High-Throughput Microfluidic Device
14:48

Generation of Dynamical Environmental Conditions using a High-Throughput Microfluidic Device

Published on: April 17, 2021

Related Experiment Videos

Last Updated: Jun 12, 2026

Disposable Dosators Intended for Dry Powder Delivery to Mice
04:59

Disposable Dosators Intended for Dry Powder Delivery to Mice

Published on: August 18, 2023

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

Generation of Dynamical Environmental Conditions using a High-Throughput Microfluidic Device
14:48

Generation of Dynamical Environmental Conditions using a High-Throughput Microfluidic Device

Published on: April 17, 2021

Area of Science:

  • Biomedical Engineering
  • Drug Delivery Systems
  • Medical Device Technology

Background:

  • Medication compliance is crucial for effective patient treatment and diagnosis.
  • Existing systems lack dynamic programmability for adapting to changing patient needs.
  • Remote control and reconfiguration are desirable features for modern medical devices.

Purpose of the Study:

  • To design, manufacture, and characterize a novel dynamically programmable e-pill dispensing system.
  • To enable remote programming and reconfiguration of pill dispensation.
  • To assess the system's performance, including battery life and operational duration.

Main Methods:

  • Development of a dynamically programmable e-pill dispensing system.
  • Implementation of remote cell phone programming and reconfiguration capabilities.
  • Characterization of the system's mechanics, electronics, control, and communication protocols.
  • Testing of battery life and operational endurance under various charging and usage scenarios.

Main Results:

  • The dynamically programmable e-pill system was successfully designed, manufactured, and characterized.
  • The system allows for remote programming and reconfiguration via cell phone.
  • Devices demonstrated over 350 hours of actuation with two pill retrievals per hour.
  • The charging circuit supports a system lifetime exceeding 6 hours after a 30-minute charge, and 14 hours with a full charge.

Conclusions:

  • The novel dynamically programmable e-pill system offers a flexible and adaptable solution for medication adherence.
  • Remote control and reconfiguration enhance the system's utility in managing patient treatment.
  • The system's robust performance and battery efficiency support its potential for clinical application.